Country for PR: Japan
Contributor: Kyodo News JBN
Tuesday, September 08 2020 - 16:00
Nippon Express Providing Global Supply Networks to Safely and Securely Deliver Pharmaceuticals Worldwide
TOKYO, Sept. 8, 2020 /Kyodo JBN, AsiaNet/ --

Nippon Express Co., Ltd. is in the process of developing pharmaceutical supply 
chain networks that meet both hardware and software requirements for Good 
Distribution Practices (standards for ensuring proper distribution of 
pharmaceuticals; hereinafter, "GDP") and thereby enable safer and more secure 
supply of pharmaceuticals.



In view of the globalization of pharmaceutical supply chains, the Company will 
also be setting up GDP-compliant business locations in major markets worldwide 
to enhance its supply networks on a global level.

Furthermore, Nippon Express will be looking to employ the digital technologies 
of IoT and blockchain to track logistics information end-to-end, doing its part 
to optimize supply chains for the industry as a whole via a data-driven 
approach that offers traceability and increased operational efficiency.

The "Nippon Express Group Management Plan 2023 -- Dynamic Growth" deems 
strengthening the Company's three approaches -- a customer-/industry-based 
approach, a business-based approach and an area-based approach -- a priority 
within the Plan's "Growth Strategy for Core Businesses." In determining how to 
optimally tailor services to the needs of individual customers, Nippon Express 
is focusing particular efforts on the customer-/industry-based approach that 
looks at services from a customer perspective.

To ensure it has in place the extensive expertise and strict quality control 
required for pharmaceutical logistics, Nippon Express created a Pharmaceuticals 
Business Division and a Pharmaceuticals Logistics Quality Assurance Office in 
July 2020 to establish uniform Group-wide standards on operational frameworks, 
human resource development, quality assurance regimes, etc.

- Global Pharmaceutical Supply Chain Networks to Enable Safe and Secure Supply 
of Pharmaceuticals
Service to Begin in Japan Next Spring and Globally Thereafter

1. Constructing supply networks in Japan
Nippon Express is currently setting up pharmaceutical-specific facilities in 
East Japan, West Japan, Kyushu and Toyama to complement the "medical hubs" of 
Narita International Airport and Kansai International Airport, which have long 
been involved in the import/export of raw materials and finished products.

These facilities will be equipped to handle GDP-compliant quality control and 
business continuity plans (BCPs) pertaining to pharmaceutical supply, and 
platforms will be constructed to allow for joint warehouse storage and 
transport, operations heretofore carried out on an individual customer basis, 
to cope with the shortages of truck drivers stemming from the round use of 
vehicles, and to achieve greater operational efficiency. These facilities will 
go into service in February 2021.


2. Expanding on a global level
Nippon Express is drawing fully on the strengths of its own global network to 
link up infrastructure and forwarding functions in developing overseas 
logistics networks that guarantee safety on a global level as required for 
pharmaceutical logistics.

More specifically, the Company is building GDP-compliant CFS at key 
pharmaceutical business locations overseas. It has already opened GDP-certified 
CFS in London and Milan, which both host clusters of manufacturers of new 
drugs, as well as in India, where generics are driving robust market growth; in 
the U.S., the world's largest market, GDP certification was acquired in 
Chicago. In addition to enhancing business locations in Europe and the U.S., 
Nippon Express is planning to obtain GDP certification in Asian countries where 
medical services are becoming more widely accessible.

The Company will continue enhancing its network in future through M&A deals and 
other means with an eye to offering storage and distribution logistics in major 
markets around the world.


3. Increasing supply chain sophistication via a data-driven approach
Nippon Express established a new Digital Platform Strategy Office in April 2020 
to provide the pharmaceutical industry and other industries with solutions 
designed to fully optimize their supply chains.

Construction is underway on a digital platform for the pharmaceutical industry 
that will utilize IoT devices and blockchain technology to link temperature 
control and other logistics information end-to-end, and there are plans to make 
use of the logistics information to develop commercial distribution services.

The Company is also teaming up with industry officials to consider making this 
digital platform an open one so that interested parties can make joint use of 



In pursuit of its social mission of becoming a driving force in society's 
development through logistics, Nippon Express will be making full use of its 
global pharmaceutical supply networks to serve its customers in the 
pharmaceutical industry and create new value through logistics.

Nippon Express website:

Official LinkedIn Account: NIPPON EXPRESS GROUP

SOURCE: Nippon Express Co., Ltd.